top of page
INSIGHTS
Search
Recent decision of Delhi High Court in the case of GILEAD PHARMASSET, LLC V. UNION OF INDIA & ANR
Recently, the Delhi high court on dated 30 th January 2015 set aside an order of the Deputy Controller of Patents and Designs. The...
Feb 23, 20153 min read
CIPLA’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government
As reported in TOI, the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for chronic obstructive pulmonary disease (COPD) drug over which Novartis has exclusive rights. We have reported on Cipla’s plea here. Background: Cipla, previously approached the Department of Industrial Policy and Promotion (DIPP) to exercise its statutory powers under Section 66 and Section 92 (3) to revoke Indian Patents IN222346, IN230049, IN
Dec 17, 20143 min read
Revised Draft Guidelines for Examination of Pharma Patent Applications
We have earlier reported the release of Draft Guidelines for Examination of Pharma Patent Applications. The Patent office has now...
Aug 22, 20143 min read
bottom of page